It has been established that TOP2A and Ki-67 antibodies can be used to screen for cervical cancer in immunocytochemical examination of cervicovaginal smears; in cervical cancer, there is an increased expression of nuclear proteins Ki-67 and type IIa DNA topoisomerase (TOP2A) [35]. This evidence concerns the gene MKI67 and cervical carcinoma.